Cargando…
Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208194/ https://www.ncbi.nlm.nih.gov/pubmed/22065966 http://dx.doi.org/10.5045/kjh.2011.46.3.148 |
| _version_ | 1782215601232543744 |
|---|---|
| author | Matsushita, Takefumi |
| author_facet | Matsushita, Takefumi |
| author_sort | Matsushita, Takefumi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3208194 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32081942011-11-07 Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology Matsushita, Takefumi Korean J Hematol Perspective Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011-09 2011-09-30 /pmc/articles/PMC3208194/ /pubmed/22065966 http://dx.doi.org/10.5045/kjh.2011.46.3.148 Text en © 2011 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Perspective Matsushita, Takefumi Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology |
| title | Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology |
| title_full | Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology |
| title_fullStr | Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology |
| title_full_unstemmed | Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology |
| title_short | Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology |
| title_sort | engineered therapeutic antibodies with enhanced effector functions: clinical application of the potelligent® technology |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208194/ https://www.ncbi.nlm.nih.gov/pubmed/22065966 http://dx.doi.org/10.5045/kjh.2011.46.3.148 |
| work_keys_str_mv | AT matsushitatakefumi engineeredtherapeuticantibodieswithenhancedeffectorfunctionsclinicalapplicationofthepotelligenttechnology |